Cardiovascular
2 drugs are in development for Cardiovascular Diseases.
- Companies
- 2
- Clinical trials
- 57
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Cardiovascular Diseases pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Ralinepag | UNITED THERAPEUTICS Corp (UTHR) |
Phase 4(1)
| Drug | Company |
|---|---|
| insulin glargine | ELI LILLY & Co (LLY) |
About this indication
Cardiovascular Diseases context
Cardiovascular·MeSH: Cardiovascular Diseases (D002318)
Also known as: Cardiovascular Disease
Prevalence
8121.9 / 100K
Incidence
682.0 / 100K/yr
Compare drugs
Frequently asked questions
How many drugs are in development for Cardiovascular Diseases?
BioSniper tracks 2 drugs in development for Cardiovascular Diseases across 2 companies.
How many clinical trials target Cardiovascular Diseases?
There are 57 clinical trials targeting Cardiovascular Diseases tracked by BioSniper.
What is the prevalence of Cardiovascular Diseases?
The estimated prevalence of Cardiovascular Diseases is approximately 8121.9 per 100,000 population.